6,7-Dimethoxy-3,4-dihydronaphthalen-1(2H)-one, 97.0%, 5g

2-(Cyclohex-1-en-1-yl)pyridine, 96.0%, 1g

1-(5-Methylpyridin-2-yl)piperidine-4-carboxylic acid, 95%, 50mg

10H-Benzo[b]pyrido[2,3-e][1,4]thiazine, 95.0%, 25g

4-Methyl-1-naphthaleneboronic acid, 95.0%, 25g

(2-(Pyrrolidin-1-yl)pyrimidin-5-yl)boronic acid, 98%, 1g

Microliter syringe MICROLITER® series 700 Point type 3, 500 µl, 750 NR, 1 piece

3-(2,4-dimethylphenyl)-1-methyl-1{H}-pyrazole-5-carboxylic acid, 95.0%, 1g

tert-Butyl 4-(2,2,2-trifluoroacetyl)piperidine-1-carboxylate, 95.0%, 1g

5-Amino-2-nitrobenzoic acid, 95.0%, 5g

3,3'-Dibromo-2,2'-bithiophene>98.0%(GC)5g

4-(4-chlorophenyl)-3-(2-methoxyphenyl)-4,5-dihydro-1H-1,2,4-triazole-5-thione, 250mg

6-chloro-1H,2H,3H-imidazo[4,5-c]pyridin-2-one, 95%, 100mg